维普中文期刊产品整合服务
59篇 您的检索式:作者名="Distler JH"
    题名 作者 年代 出处 被引量
1Vascular changes in pathogenesis of systemic sclerosis显示文摘Distler JH Kalden JR Gray S 2004Z Rheumtor2004,63,6:1
2Expression of in- terleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis 显示文摘Jtingel A Distler JH Kurowska-Stolarska M 2004Arthritis Rheum2004,50,5:1
3The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles显示文摘Distler JH Jungel A Huber LC 2005Proc Nail Acad Sci USA2005,102,8:1
4Mieropartieles as mediators of cellular cross-talk in inflammatory disease 显示文摘Distler JH Huber LC Gay S 2006Autoimmunity2006,39,8:1
5Angiogenic and angiostatic factors in the molecular control of angiogenesis 显示文摘Distler JH Hirth A Kurowska-Stolarska M 2003Q J Nucl Med2003,47,3:1
6Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis显示文摘Distler O Distler JH Scheid A 2004Circ Res2004,95,1:1
7Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis 显示文摘Distler JH Wenger RH Gassmann M 2004Arthritis Rheum2004,50,1:1
8Tyrosine kinase signaling in fibrotic disorders:Translation of basic research to human disease显示文摘Beyer C Distler JH 2013Biochim Biophys Acta2013,1832,7:1
9Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis 显示文摘Distler JH Jungel A Huber LC 2007Arthritis Rheum2007,56,1:1
10Treatment of pulmonary fibrosis for twenty weeks with imatinib mesylate in a patient with mixed connective tissue disease 显示文摘Distler JH Manger B Spriewald BM 2008Arthritis Rheum2008,58,8:1
11The release of microparticles by apoptotic cells and their effects on macrophages显示文摘Distler JH Huber LC Hueber AJ 0,,:1
12Angiogenic and angiostatic factors in the molecular control of angiogenesis显示文摘Distler JH Hirth A Kurowska-Stolarska M 2003Q J Nucl Med2003,47,:1
13Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis显示文摘Distler JH Jungel A Kowal-Bielecka O 2005Arthritis Rheum2005,52,:1
14Tyrosine kinaseinhibitors for the treatment of fibrotic diseases such as systemic sclerosis:towards molecular targeted therapies显示文摘Distler JH Distler O 2010Ann Rheum Dis2010,69,1:1
15Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibre- blasts and synovial macrophages of patients with rheumatoid arthritis 显示文摘Jungel A Distler JH Kurowska-Stolarska M 2004Arthritis Rheum2004,50,5:1
16Endothelial progenitorcells : novel players in the pathogenesis of rheumatic diseases显示文摘Distler JH Beyer C Schett G 2009Arthritis Rheum2009,60,:1
17Tyrosine kinase inhibitors in the treatment of systemic sclerosis:from animal models to clinical trials显示文摘Iwamoto N Distler JH Distler O 2011Curr Rheumatol Rep2011,13,1:1
18Angiogenie and angiostatic factom in the molecular control of anglogenesis显示文摘Distler JH Hirth A Kurowska-Stolarska M 2003Q J Nucl Med2003,47,3:1
19Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis显示文摘Huber LC Distler JH Moritz F 2007Arthritis Rheum2007,56,8:1
20Morphogen pathways in systemic sclerosis显示文摘Beyer C Distler JH 2013Curr Rheumatol Rep2013,15,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费